ACLU Against Drug for Executions - The Missourian: Letters To The Editor

default avatar
Welcome to the site! Login or Signup below.
|
||
Logout|My Dashboard

ACLU Against Drug for Executions

Print
Font Size:
Default font size
Larger font size

Posted: Saturday, August 4, 2012 5:00 pm

To The Editor:

Missouri may soon become the first state to use the drug propofol for an execution.

Being “first” in this context is a dubious distinction for several reasons, not the least of which is that propofol is the drug that gained notoriety in the death of Michael Jackson; but more to the point, it has never been used in the United States for executions.

The ACLU is against capital punishment first and foremost because it fails to meet the constitutional standard, but instead imposes cruel and unusual punishment, which is prohibited by the Bill of Rights.

In this context, we strongly oppose the added injustice of using a drug whose protocol has not been sufficiently evaluated by our court system. For example, since medical staff is not required to participate in Missouri executions, what is the risk that propofol could be administered incorrectly and prolong the killing, compounding the cruelty to the condemned?

At the very least, we should take the time to evaluate the new protocol to determine if it is consistent with the law before using it in any executions. In the high stakes of taking life, “oops” is not an acceptable risk. Not even once.

/opinion/letters_to_the_editor
(%remaining%) Remaining Thanks for visiting The Missourian. You're entitled to view 20 free articles every 30 days. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thanks for visiting The Missourian. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining We hope you will enjoy this free article on The Missourian. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining We hope you will enjoy this free article on The Missourian. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You have viewed (%remaining%) of your 20 free pages in 30 days. Please login or register at this time and enjoy the next (%remaining%) articles free of charge. After your 20 free articles, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. Because you have already viewed this article, you may view it again as many times as you would like without subtracting from your remaining free article views.
(%remaining%) Remaining Thank you for registering on The Missourian. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You're entitled to view 20 articles for free every 30 days. This is your last free article this period. On your next article we'll ask you to purchase an affordable subscription.

Featured Ads